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Article / Clinical Case Report
ABSTRACT
Peripheral Ameloblastoma (PA) is a benign odontogenic tumor, arising from the cell rest of Serres, reduced enamel 
epithelium and basal cells of the surface epithelium. Peripheral ameloblastoma is a rare odontogenic neoplasm occurring 
commonly in the mandibular gingiva. PA clinically resembles other peripherally occurring lesions like pyogenic granuloma, 
peripheral ossifying fibroma, peripheral giant cell granuloma, and squamous papilloma. The recurrence rate of PA is 
16-19% which demands a straight follow up. We report a case of recurrent peripheral ameloblastoma occurring in a 
72-year old male located in the mandibular lingual gingiva in relation to the 44, 45 element’s regions. The patient had 
a primary lesion excised from the same site 6 years before which was diagnosed as ameloblastoma. 
Keywords 
Ameloblastoma, Jaw neoplasm, Neoplasm recurrence, local odontogenic tumors.
INTRODUCTION
Peripheral ameloblastoma (PA) is a benign 
odontogenic tumor arising from the odontogenic 
epithelium with no influence of the ectomesenchyme. 
The WHO histological classification of tumors of the 
oral cavity (2017) included the extraosseous/peripheral 
ameloblastoma as one of the variants of ameloblastoma; 
thus, the origin of PA is similar. The tumor cell arises 
from the cell rest of Serres, the remnants of reduced 
enamel epithelium and the basal cells of the surface 
epithelium.1 Clinically PA is less aggressive than 
the conventional ameloblastoma and is considered 
as a hamartomatous lesion.2 The term “peripheral 
ameloblastoma” was first coined by Kuru in 1911 
and until 2014 less than 200 cases of PA have 
been reported.3 It is a rare and unusual variant of 
odontogenic tumors with the prevalence of 1-5%. 
PA is most commonly noticed in the 5th and 6th decade 
of life in contrast to intraosseous ameloblastoma, 
which presents in younger age.4 PA shows a slight 
male predilection. The lingual aspect of the mandibular 
premolar is the most involved site. Clinically it presents 
as an exophytic tumor arising from the soft tissue of 
the tooth-bearing and is usually misinterpreted as 
a fibrous epulis or a pyogenic granuloma. PA is an 
indolent tumor that doesn’t invade the underlying 
bone; however, occasionally, a mild erosion may 
invade the cortical bone without reaching the bone 
marrow. The recurrence rate is reportedly low and is 
not attributed to the disease behavior but the result 
of incomplete excision.5 Herein we report a case of 
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recurrent peripheral ameloblastoma arising in the 
lingual aspect of mandibular premolar in a 72- years 
old male patient.
CASE REPORT
A 72- year old male patient attended the 
department of oral pathology for evaluation of a 
painless gingival growth in the premolar region of 
the right mandible. This lesion has been growing over 
the last year. The patient referred the excision of a 
similar lesion 6 years before which was diagnosed as 
ameloblastoma, but unfortunately, he did not have 
the previous documentation. His past medical history 
also included the diagnosis of diabetes mellitus that 
was on regular control. The examination revealed an 
oval-shaped exophytic mass of 1×1 cm in the lingual 
gingiva of the right mandible at the first and second 
premolar region. The surface was pebbly, with a sessile 
base and firm on palpation. No local enlarged lymph 
nodes were identified (Figure 1).
The Orthopantomography (OPG) showed no 
evidence of bone involvement. The initial working 
diagnosis was pyogenic granuloma though the 
suspicion of recurrence of ameloblastoma was not 
ruled out (Figure 2).
An incisional biopsy was done, considering the 
previous history of ameloblastoma and upon the 
microscopic examination, the diagnosis of pseudo 
epitheliomatous hyperplasia was made (Figure 3). 
However, complete excision was performed because 
the initial diagnosis was not convincing. The analysis 
of excisional biopsy showed numerous proliferating 
odontogenic epithelial islands spreading throughout 
the moderately dense connective tissue stroma. 
The odontogenic epithelial islands were mainly of 
follicular pattern with peripheral hyperchromatic 
palisaded columnar cells resembling ameloblasts. 
The center of the follicle disclosed stellate reticulum 
like cells. In some of the odontogenic epithelial islands, 
the central cells underwent squamous metaplasia with 
keratin formation.
The overlying stratified squamous epithelium was 
proliferative and was found to be in close association 
with the odontogenic epithelial islands in few areas. 
A moderate amount of chronic inflammation was 
depicted in the subepithelial zone. No inductive effect 
was noticed around the odontogenic epithelial islands. 
The histopathological diagnosis of the peripheral 
ameloblastoma-acanthomatous variant was made 
(Figures 4A, 4B, and 4C). The immunohistochemical 
study was carried out with CK 19, and positive 
expression was found (Figure 4D). No recurrence 
was evidenced during the first two-month follow up. 
Figure 1. Clinical examination: showing an exophytic 
growth in the lingual aspect of the right mandibular 
premolars area.
Figure 2. Radiographic examination: without bone 
involvement.
Figure 3. Photomicrograph of the incisional biopsy 
specimen showing pseudo epitheliomatous hyperplasia.
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Considering the recurrent nature of the lesion, a 
regular follow up every six months was scheduled.
DISCUSSION
In 1959 Stanley and Krogh took the privilege 
of  document ing the f i rs t  case of  per iphera l 
ameloblastoma.6 PA predominantly occurs in the 
gingiva and also named as “Gingival ameloblastoma”.7 
Though, PA is an indolent tumor with the recurrence 
rate 16-19%; their recurrence as ameloblastic 
carcinomas, makes the follow up mandatory.2 The size 
of the lesions barely crosses 4 cm resembling epulis 
and benign tumors like papilloma. PA often presents 
with papillary projections imposing quite often the 
differential diagnosis with pyogenic granulomas.8 PA is 
commonly found in the lingual mandibular gingiva 
of the premolar region. PA is defined as a “benign 
neoplasm or hamartomatous lesion confined to the 
soft tissues overlying the tooth-bearing areas of the 
jaws or alveolar mucosa in the edentulous area”. This 
definition has not included the extra gingival lesions 
that occur in the buccal mucosa, lips, palate, and floor 
of the mouth. It has been hypothesized that the buccal 
mucosal lesions have more chances of having its origin 
from the salivary excretory ducts. Odontogenic epithelial 
gingival hamartoma (OEGH) or odontogenic epithelial 
hamartoma (OEH) is another entity, which is similar to 
PA on clinical and histopathological grounds, though 
failed to substantiate since the reported cases were 
only six. Initially, few cases of PA were misdiagnosed 
as intraoral basal cell carcinomas (IOBCC) on the 
Figure 4. Photomicrographs of the surgical specimen showing in A - islands of odontogenic epithelium present close 
to the surface epithelium (H&E, 4X); B - Odontogenic epithelial islands with palisading peripheral cells (H&E, 10X); 
C - Central squamous metaplasia of odontogenic epithelium (H&E, 40X); D - CK  19 positivity.
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clinical and histopathological features, which were 
later overcome with the aid of Immunohistochemistry. 
PA shows strong positivity for calretinin, CK 5, 14, 19 
and amelogenin, whereas most of the mesenchymal 
odontogenic tumors do not express these markers. 
Intraoral basal carcinoma is ruled out by evaluating 
their positivity for Bcr-Ep4.9,10
PA presents itself as a rare benign odontogenic 
neoplasm, that mostly occurs in the lingual gingiva 
of mandibular premolar region (as in the index case), 
followed by the anterior mandible and maxillary 
tuberosity region. The occurrence ratio between 
maxilla and mandible is 1:2.5.2 PA occurring in a 
remote area like pterygomandibular space is also 
documented in the literature.11 PA occurs in a wide 
range of age, between 16-92 years.12
Clinically, PA presents as a solid lesion with a 
surface ranging from smooth, granular and warty 
or papillary, similar to the normal mucosa coloration 
like in our case. However, the tumor may take a 
darker hue.2 Our case was a recurrence after 6 years 
from the first excision, in the lingual mandibular 
gingiva with a papillary surface. The recurrence 
rate of PA is 16 to 19%,2 therefore a long term 
follow-up is mandatory, since chances are there for 
benign-appearing peripheral ameloblastoma to reoccur 
as ameloblastic carcinoma.2
PA originates from (i) the remnants of dental lamina 
in the gingiva, (ii) the pluripotent cells of the basal layer 
of the surface epithelium, and (iii) the pluripotential 
cells of the minor salivary gland.13 Macroscopically the 
cut sections of the tumor exhibit very tiny fluid-filled 
cystic spaces that were the most similar feature of 
our case.2 Microscopically, PA exhibits proliferating 
odontogenic epithelium as separate islands and chords 
resembling the odontogenic islands of the central 
ameloblastoma. The islands are also found to be very 
closely related to the overlying surface epithelium 
and surrounded by mature fibrous connective tissue 
characteristically without any calcifications. The islands 
take a more follicular pattern with the acanthomatous 
change of the stellate reticulum like cells making the 
stellate reticulum component less conspicuous. Group 
of basaloid cells with acanthomatous areas resembles 
basal cell carcinoma making the diagnosis of PA 
difficult. The presence of clear cells and ghost cells 
in the acanthomatous area facilitates the inclusion of 
other benign and malignant odontogenic tumors in 
the differential diagnosis.
The histopathological presentation of our case 
follows the pattern of the traditional peripheral 
ameloblastomas, such as the predominance of 
acanthomatous differentiation of the follicles with 
keratin formation. The surrounding connective tissue is 
of mature fibrous type. The peripheral ameloblast - like 
cells exhibited a reversal of polarity in fewer follicles. 
Few islands are found close to the surface epithelium. 
The inductive effect was not noticed adjacent to 
the islands. The inflammatory component was also 
observed subjacent to the epithelium.
The immunohistochemical study ameloblastomas 
express cytokeratins 5/6, 13, 14, and 19. CK13 is 
preferentially expressed in the stellate reticulum like 
cells, CK14 in peripheral cells and CK19 in all cells.14
The lesion was excised entirely in a conservative 
approach. Our case completed two months of follow 
up with no signs of relapse.
The recent molecular pathogenesis elucidated 
for ameloblastomas includes recurrent activating 
mutations in FGFR2, BRAF, and RAS, leading to 
dysregulation of the MAPK pathway. Secondary 
mutations are assumed to disrupt the SMO and SHH 
pathways.
Mutat ion of  BRAF V600E enhances  ce l l 
proliferation, survival, and neoplastic transformation. 
Together FGFR2, RAS and BRAF mutations are found 
in around 78-88% of ameloblastomas. Also, there is 
accumulating evidence that there exists a potential 
role for inhibitors of BRAF, dabrafenib observed in 
therapeutic clinical trials.15
To conclude, peripheral ameloblastoma a benign 
tumor, duly differentiated histopathologically from 
other clinically similar lesions. Immunohistochemical 
analysis using a panel of markers may aid involving 
misinterpretations. Complete surgical excision is 
advised with thorough microscopic evaluation of 
the margins for any odontogenic islands, which may 
contribute to recurrences.
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